Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M157Revenue $M6.1Net Margin (%)--Altman Z-Score12.3
Enterprise Value $M83.7EPS $-1.1Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.0Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %--Quick Ratio13.4Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio13.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-44.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-48.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M44.1ROIC % (ttm)-198.6Gross Margin Increase y-yN

Gurus Latest Trades with CCXI

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CCXI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CCXI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-22Sell25,764$4.04-11.88view
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-20Sell21,405$4.08-12.75view
Parker Geoffrey M.Director 2016-01-11Buy20,000$4.63-23.11view
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-08Sell10,224$5.12-30.47view
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-06Sell47,607$6.98-49view
Parker Geoffrey M.Director 2015-12-11Buy20,000$7.25-50.9view
BIOTECHNOLOGY VALUE FUND L P 2015-11-04Sell360,000$7-49.14view
BIOTECHNOLOGY VALUE FUND L P 2015-11-02Sell50,000$6.97-48.92view
BVF PARTNERS L P/IL10% Owner 2015-06-10Sell955,700$9-60.44view
Parker Geoffrey M.Director 2015-05-27Sell13,513$7.51-52.6view

Quarterly/Annual Reports about CCXI:

    News about CCXI:

    Articles On GuruFocus.com
    Three Attractively Priced Small Cap Biotech Stocks Nov 05 2014 

    More From Other Websites
    ChemoCentryx to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 07 2016
    ChemoCentryx rare-disease drug as effective as standard of care Jan 06 2016
    ChemoCentryx drug meets main goal in mid-stage study Jan 06 2016
    ChemoCentryx Announces Positive Results in Phase II ANCA-Associated Vasculitis CLEAR Trial of Orally... Jan 06 2016
    Biotechnology Equities Update -- Arena Pharma, Compugen, ChemoCentryx, and Concert Pharma Dec 23 2015
    A Change in Tides - Analyst Notes on Hemisphere Media Group, AngioDynamics, ChemoCentryx and... Dec 17 2015
    CHEMOCENTRYX, INC. Financials Dec 08 2015
    What Do Hedge Funds Think of Blount International, Inc. (BLT)? Dec 02 2015
    ChemoCentryx (CCXI) Shares March Higher, Can It Continue? Dec 02 2015
    Hedge Funds Are Crazy About Panhandle Oil and Gas Inc. (PHX) Nov 30 2015
    Hedge Funds Are Selling Navios Maritime Holdings Inc. (NM) Nov 26 2015
    What Makes a Chart Move? – Research on Zix, DavidsTea, ChemoCentryx and Genie Energy Nov 18 2015
    ChemoCentryx to Present at Two Upcoming Investor Conferences Nov 12 2015
    ChemoCentryx reports 3Q loss Nov 09 2015
    ChemoCentryx reports 3Q loss Nov 09 2015
    ChemoCentryx Inc Earnings Call scheduled for 5:00 pm ET today Nov 09 2015
    ChemoCentryx to Hold Third Quarter 2015 Financial Results Conference Call on Monday, November 9,... Nov 09 2015
    CHEMOCENTRYX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 09 2015
    ChemoCentryx Reports Third Quarter 2015 Financial Results and Provides Corporate Update Nov 09 2015
    ChemoCentryx to Present at the Rodman & Renshaw 17th Annual Global Investment Conference Sep 02 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK